Trial Profile
A prospective study to investigate the efficacy and the safety of daclatasvir plus asunaprevir therapy in elderly patients with hepatitis C virus genotype 1 infection in Japan
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2016
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 14 Mar 2016 New trial record